Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 301 - 325 of 338 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▼
Diacylglycerophosphoinositolglycans LMGP15010009
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:0)
126457377 986.594308 C48H91O18P
Diacylglycerophosphoinositolglycans LMGP15010032
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/14:0)
126457400 986.594308 C48H91O18P
Diacylglycerophosphoinositolglycans LMGP15010010
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:1(9Z))
126457378 984.578658 C48H89O18P
Diacylglycerophosphoinositolglycans LMGP15010038
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/14:0)
126457406 984.578658 C48H89O18P
Diacylglycerophosphoinositolglycans LMGP15010011
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/16:2(9Z,12Z))
126457379 982.563008 C48H87O18P
Diacylglycerophosphoinositolglycans LMGP15010044
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/14:0)
126457412 982.563008 C48H87O18P
Diacylglycerophosphoinositolglycans LMGP15010003
  • 2'-O-(alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:0)
126457371 972.578658 C47H89O18P
Diacylglycerophosphoinositolglycans LMGP15010014
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/14:0)
126457382 972.578658 C47H89O18P
Diacylglycerophosphoinositolglycans LMGP15010004
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:1(9Z))
126457372 970.563008 C47H87O18P
Diacylglycerophosphoinositolglycans LMGP15010020
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/14:0)
126457388 970.563008 C47H87O18P
Diacylglycerophosphoinositolglycans LMGP15010005
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/16:2(9Z,12Z))
126457373 968.547358 C47H85O18P
Diacylglycerophosphoinositolglycans LMGP15010026
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/14:0)
126457394 968.547358 C47H85O18P
Diacylglycerophosphoinositolglycans LMGP15010008
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/14:0)
126457376 958.563008 C46H87O18P
Monoacylglycerophosphoinositolglycans LMGP15040022
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(19:0/0:0)
126457679 1100.501593 C46H85O27P
Monoacylglycerophosphoinositolglycans LMGP15040023
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(19:1(9Z)/0:0)
126457680 1098.485943 C46H83O27P
Monoacylglycerophosphoinositolglycans LMGP15040024
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(19:2(9Z,12Z)/0:0)
126457681 1096.470293 C46H81O27P
Diacylglycerophosphoinositolglycans LMGP15010002
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/14:0)
126457370 944.547358 C45H85O18P
Monoacylglycerophosphoinositolglycans LMGP15040019
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(18:0/0:0)
126457676 1086.485943 C45H83O27P
Monoacylglycerophosphoinositolglycans LMGP15040020
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(18:1(9Z)/0:0)
126457677 1084.470293 C45H81O27P
Monoacylglycerophosphoinositolglycans LMGP15040021
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(18:2(9Z,12Z)/0:0)
126457678 1082.454643 C45H79O27P
Monoacylglycerophosphoinositolglycans LMGP15040018
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(17:0/0:0)
126457675 1072.470293 C44H81O27P
Monoacylglycerophosphoinositolglycans LMGP15040017
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM3(16:0/0:0)
126457674 1058.454643 C43H79O27P
Monoacylglycerophosphoinositolglycans LMGP15040014
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(19:0/0:0)
126457671 938.448768 C40H75O22P
Monoacylglycerophosphoinositolglycans LMGP15040015
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(19:1(9Z)/0:0)
126457672 936.433118 C40H73O22P
Monoacylglycerophosphoinositolglycans LMGP15040016
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM2(19:2(9Z,12Z)/0:0)
126457673 934.417468 C40H71O22P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024